Elequin Capital’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11
Closed -$457 661
2023
Q2
$457 Buy
+11
New +$452 ﹤0.01% 496
2022
Q3
Sell
-222
Closed -$11K 717
2022
Q2
$11K Buy
222
+119
+116% +$6.38K ﹤0.01% 236
2022
Q1
$6K Buy
+103
New +$5.47K ﹤0.01% 212

Other funds holding NUVA

Elequin Capital's NUVA Position: Q3 2023 in Review

Elequin Capital sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 11 shares — an estimated $457 sold.

Elequin Capital first reported a position in NUVA in Q1 2022 and held it in 3 quarters. The position peaked at $11K in Q2 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Elequin Capital reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Elequin Capital sold 11 NuVasive, Inc. shares in Q3 2023, an estimated $457.
  • Elequin Capital first reported a position in NuVasive, Inc. in Q1 2022 and held it in 3 quarters.
  • Elequin Capital's NuVasive, Inc. position peaked at $11K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Elequin Capital's 13F filing for Q3 2023, filed 14 Nov 2023.